Pharamax

estudios

Remember:

Our Research begins with YOU!

CURRENT STUDIES

Our center is conducting multiple clinical trials for patients with an active medical diagnosis in any of the conditions listed in this page.  By "active”, we mean you currently meet the criteria for your condition. By "medical diagnosis”, we mean that a diagnosis has been made by a qualified physician and there is a documented medical record of such condition.

Fatty Liver

  • Age Groups: 18-90 years old
  • Gender: Males and Females
  • Duration: 58 weeks aprox.
  • Required Visits: 15 onsite
  • For patients with nonalcoholic steatohepatitis and liver fibrosis

Learn more about this study

Low testosterone

  • Age Groups: 45-80 years
  • Gender: Males
  • Duration: 89 weeks aprox.
  • Required Visits: 29 onsite and 8 phone calls
  • For males with low testosterone and history of cardiovascular events or cardiovascular risks

Learn more about this study

 

Ulcerative colitis

  • Age Groups: 18-75 years of age
  • Gender: Males and Females
  • Duration: Up to 55 weeks aprox.
  • Required Visits: 41 onsite
  • For patients suffering moderate to severe ulcerative colitis

Learn more about this study

Mayor depressive disorder

  • Age Groups: 18-74 years
  • Gender: Males and Females
  • Duration: 57 days
  • Required Visits: 8 onsite and 3 phone calls
  • For adults and elderly patients suffering MDD with insomnia

Learn more about this study

Pneumococcal vaccine

  • Age Groups: 15 months through 25 years of age
  • Gender: Males and Females
  • Duration: 6 months
  • Required Visits: 2 onsite and 1 phone call
  • For healthy children, adolescents and adults that received Prevnar 13 previously

Learn more about this study

Prevention of colorectal cancer

  • Age Groups: 45 and 85 (inclusive) years of age
  • Gender: Males and Females
  • Duration: 90 days
  • Required Visits: 2 onsite
  • For patients who are at average risk of developing CRC

Learn more about this study

Meningococcal vaccine

  • Age Groups: 15-25 years of age
  • Gender: Males and Females
  • Duration: 365 days
  • Required Visits: 4 onsite and 5 phone calls
  • For healthy adolescents and adults

Learn more about this study

Hypertension

  • Age Groups: 18 - 75 years old
  • Gender: Males and Females
  • Duration: 24 weeks aprox.
  • Required Visits: 20 clinic visits
  • For patients with untreated hypertension or on stable therapy

Learn more about this study

RSV vaccine

  • Age Groups: 60 - 64 years of age
  • Gender: Males and Females
  • Duration: 6 months
  • Required Visits: 2 onsite and 3 safety phone calls
  • Prophylactic immunotherapy for respiratory syncytial virus (RSV)

Learn more about this study

Atherosclerotic hearth disease

  • Age Groups: 18 years and above
  • Gender: Males and Females
  • Duration: Up to 45 months aprox.
  • Required Visits: 22 onsite
  • For patients with established atherosclerotic cardiovascular disease, CKD and systemic inflamation

Learn more about this study